115 filings
Page 3 of 6
8-K
tzyegb50 n19
2 Nov 22
Other Events
6:07am
DEFA14A
t0nm2yqo1qelvbp
27 Oct 22
Additional proxy soliciting materials
4:15pm
DEFA14A
my3 91gomowh95506
27 Oct 22
Additional proxy soliciting materials
4:11pm
8-K
7d9qv1a4 nit2oy2
27 Oct 22
Entry into a Material Definitive Agreement
4:06pm
DEFA14A
fkdyy7k02f6a1
21 Oct 22
Additional proxy soliciting materials
7:46am
8-K
8d0jbmi6ktz0d1dv7
21 Oct 22
Other Events
7:36am
UPLOAD
mekjztpvsnudgeq fx2
7 Oct 22
Letter from SEC
12:00am
DEFM14A
7nvorssnr66ufryy
6 Oct 22
Proxy related to merger
4:16pm
8-K
6v9c atyfmn
30 Sep 22
Entry into a Material Definitive Agreement
4:07pm
PRER14A
o3ts hgx3
16 Sep 22
Preliminary revised proxy
4:56pm
CORRESP
ziine
16 Sep 22
Correspondence with SEC
12:00am
UPLOAD
xuvfg4fo3rw80
9 Sep 22
Letter from SEC
12:00am
8-K
naw9a 5zqvdmn64a
2 Sep 22
Departure of Directors or Certain Officers
4:05pm
PREM14A
ib6m w3xwydzt33
11 Aug 22
Preliminary proxy related to merger
5:22pm
DEFA14A
89v0wa gucoay
21 Jul 22
Additional proxy soliciting materials
5:05pm
8-K
vpv7o8wo c4
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
8-K
q7p3d znu5c220mp
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
u9al gz0asff2grzmdna
12 May 22
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
4:11pm